Granulocyte antibody detection – the role of MPHA
Identifieur interne : 000642 ( Istex/Corpus ); précédent : 000641; suivant : 000643Granulocyte antibody detection – the role of MPHA
Auteurs : N. H. Tsuno ; M. Matsuhashi ; K. TakahashiSource :
- ISBT Science Series [ 1751-2816 ] ; 2011-12.
English descriptors
- Teeft :
- Acute lung injury, Antigenicity, Araki, Assay, Blood transfusion, Cell lines, Chloroquine, Clinical conditions, Granulocyte, Granulocyte antibodies, Granulocyte antigens, Granulocyte immunobiology, Granulocyte serology, Immunobiology, Immunology, Indicator cells, International society, Isbt, Isbt science series, Magnetic beads, Maiga, Microtitre, Monoclonal, Monoclonal immobilization, Mpha, Mpha assay, Neutropenia, Neutrophil, Platelet, Serology, Trali, Transfusion, Tsuno.
Abstract
Human neutrophil antigens (HNA) are involved in the pathogenesis of a variety of clinical conditions, such as neonatal immune neutropenia (NIN), refractoriness to granulocyte transfusions, alloimune neutropenia after bone marrow transplantation, febrile transfusion reactions, and transfusion‐related acute lung injury (TRALI). The accurate detection of granulocyte antibodies is essential for the diagnosis and prevention of the clinical conditions in which these antibodies are involved, especially TRALI. The international granulocyte immunology workshop recommends the use of granulocyte agglutination test (GAT) and granulocyte immunofluorescence test (GIFT) for the screening of granulocyte antibody, and the use of monoclonal antibody‐specific immobilization of granulocyte antigen (MAIGA) assay for the determination of the antibody specificity. Presently, however, no single technique available is enough to detect all clinically relevant granulocyte antibodies. Here, we describe the advantages and disadvantages of the mixed‐passive hemagglutination (MPHA) assay in the general context of granulocyte serology.
Url:
DOI: 10.1111/j.1751-2824.2011.01520.x
Links to Exploration step
ISTEX:F9ACF182FF33253B045DC88AB200CDA320ED3514Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Granulocyte antibody detection – the role of MPHA</title><author><name sortKey="Tsuno, N H" sort="Tsuno, N H" uniqKey="Tsuno N" first="N. H." last="Tsuno">N. H. Tsuno</name><affiliation><mods:affiliation>Department of Transfusion Medicine, The University of Tokyo, Tokyo, Japan</mods:affiliation></affiliation></author><author><name sortKey="Matsuhashi, M" sort="Matsuhashi, M" uniqKey="Matsuhashi M" first="M." last="Matsuhashi">M. Matsuhashi</name><affiliation><mods:affiliation>Department of Transfusion Medicine, The University of Tokyo, Tokyo, Japan</mods:affiliation></affiliation></author><author><name sortKey="Takahashi, K" sort="Takahashi, K" uniqKey="Takahashi K" first="K." last="Takahashi">K. Takahashi</name><affiliation><mods:affiliation>Department of Transfusion Medicine, The University of Tokyo, Tokyo, Japan</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F9ACF182FF33253B045DC88AB200CDA320ED3514</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1111/j.1751-2824.2011.01520.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-XMLB41H6-R/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000642</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000642</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Granulocyte antibody detection – the role of MPHA</title><author><name sortKey="Tsuno, N H" sort="Tsuno, N H" uniqKey="Tsuno N" first="N. H." last="Tsuno">N. H. Tsuno</name><affiliation><mods:affiliation>Department of Transfusion Medicine, The University of Tokyo, Tokyo, Japan</mods:affiliation></affiliation></author><author><name sortKey="Matsuhashi, M" sort="Matsuhashi, M" uniqKey="Matsuhashi M" first="M." last="Matsuhashi">M. Matsuhashi</name><affiliation><mods:affiliation>Department of Transfusion Medicine, The University of Tokyo, Tokyo, Japan</mods:affiliation></affiliation></author><author><name sortKey="Takahashi, K" sort="Takahashi, K" uniqKey="Takahashi K" first="K." last="Takahashi">K. Takahashi</name><affiliation><mods:affiliation>Department of Transfusion Medicine, The University of Tokyo, Tokyo, Japan</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">ISBT Science Series</title><title level="j" type="sub">State of the Art Presentations, 22nd Regional Congress of the ISBT – Asia, Taipei, Taiwan, November 19–23, 2011</title><title level="j" type="alt">ISBT SCIENCE SERIES</title><idno type="ISSN">1751-2816</idno><idno type="eISSN">1751-2824</idno><imprint><biblScope unit="vol">6</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="387">387</biblScope><biblScope unit="page" to="390">390</biblScope><biblScope unit="page-count">4</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2011-12">2011-12</date></imprint><idno type="ISSN">1751-2816</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1751-2816</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acute lung injury</term><term>Antigenicity</term><term>Araki</term><term>Assay</term><term>Blood transfusion</term><term>Cell lines</term><term>Chloroquine</term><term>Clinical conditions</term><term>Granulocyte</term><term>Granulocyte antibodies</term><term>Granulocyte antigens</term><term>Granulocyte immunobiology</term><term>Granulocyte serology</term><term>Immunobiology</term><term>Immunology</term><term>Indicator cells</term><term>International society</term><term>Isbt</term><term>Isbt science series</term><term>Magnetic beads</term><term>Maiga</term><term>Microtitre</term><term>Monoclonal</term><term>Monoclonal immobilization</term><term>Mpha</term><term>Mpha assay</term><term>Neutropenia</term><term>Neutrophil</term><term>Platelet</term><term>Serology</term><term>Trali</term><term>Transfusion</term><term>Tsuno</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Human neutrophil antigens (HNA) are involved in the pathogenesis of a variety of clinical conditions, such as neonatal immune neutropenia (NIN), refractoriness to granulocyte transfusions, alloimune neutropenia after bone marrow transplantation, febrile transfusion reactions, and transfusion‐related acute lung injury (TRALI). The accurate detection of granulocyte antibodies is essential for the diagnosis and prevention of the clinical conditions in which these antibodies are involved, especially TRALI. The international granulocyte immunology workshop recommends the use of granulocyte agglutination test (GAT) and granulocyte immunofluorescence test (GIFT) for the screening of granulocyte antibody, and the use of monoclonal antibody‐specific immobilization of granulocyte antigen (MAIGA) assay for the determination of the antibody specificity. Presently, however, no single technique available is enough to detect all clinically relevant granulocyte antibodies. Here, we describe the advantages and disadvantages of the mixed‐passive hemagglutination (MPHA) assay in the general context of granulocyte serology.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>granulocyte</json:string><json:string>mpha</json:string><json:string>chloroquine</json:string><json:string>isbt</json:string><json:string>transfusion</json:string><json:string>assay</json:string><json:string>indicator cells</json:string><json:string>platelet</json:string><json:string>isbt science series</json:string><json:string>neutrophil</json:string><json:string>maiga</json:string><json:string>trali</json:string><json:string>antigenicity</json:string><json:string>granulocyte antigens</json:string><json:string>microtitre</json:string><json:string>monoclonal</json:string><json:string>immunology</json:string><json:string>serology</json:string><json:string>tsuno</json:string><json:string>granulocyte antibodies</json:string><json:string>granulocyte immunobiology</json:string><json:string>immunobiology</json:string><json:string>neutropenia</json:string><json:string>araki</json:string><json:string>clinical conditions</json:string><json:string>granulocyte serology</json:string><json:string>international society</json:string><json:string>cell lines</json:string><json:string>blood transfusion</json:string><json:string>magnetic beads</json:string><json:string>monoclonal immobilization</json:string><json:string>mpha assay</json:string><json:string>acute lung injury</json:string></teeft></keywords><author><json:item><name>N. H. Tsuno</name><affiliations><json:string>Department of Transfusion Medicine, The University of Tokyo, Tokyo, Japan</json:string></affiliations></json:item><json:item><name>M. Matsuhashi</name><affiliations><json:string>Department of Transfusion Medicine, The University of Tokyo, Tokyo, Japan</json:string></affiliations></json:item><json:item><name>K. Takahashi</name><affiliations><json:string>Department of Transfusion Medicine, The University of Tokyo, Tokyo, Japan</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>GAT</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>GIFT</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Human neutrophil antigens</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>MAIGA</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>MPHA</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>TRALI</value></json:item></subject><articleId><json:string>VOXS1520</json:string></articleId><arkIstex>ark:/67375/WNG-XMLB41H6-R</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>Human neutrophil antigens (HNA) are involved in the pathogenesis of a variety of clinical conditions, such as neonatal immune neutropenia (NIN), refractoriness to granulocyte transfusions, alloimune neutropenia after bone marrow transplantation, febrile transfusion reactions, and transfusion‐related acute lung injury (TRALI). The accurate detection of granulocyte antibodies is essential for the diagnosis and prevention of the clinical conditions in which these antibodies are involved, especially TRALI. The international granulocyte immunology workshop recommends the use of granulocyte agglutination test (GAT) and granulocyte immunofluorescence test (GIFT) for the screening of granulocyte antibody, and the use of monoclonal antibody‐specific immobilization of granulocyte antigen (MAIGA) assay for the determination of the antibody specificity. Presently, however, no single technique available is enough to detect all clinically relevant granulocyte antibodies. Here, we describe the advantages and disadvantages of the mixed‐passive hemagglutination (MPHA) assay in the general context of granulocyte serology.</abstract><qualityIndicators><score>5.776</score><pdfWordCount>2060</pdfWordCount><pdfCharCount>12987</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>4</pdfPageCount><pdfPageSize>595.276 x 799.37 pts</pdfPageSize><pdfWordsPerPage>515</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>143</abstractWordCount><abstractCharCount>1121</abstractCharCount><keywordCount>6</keywordCount></qualityIndicators><title>Granulocyte antibody detection – the role of MPHA</title><genre><json:string>article</json:string></genre><host><title>ISBT Science Series</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1751-2824</json:string></doi><issn><json:string>1751-2816</json:string></issn><eissn><json:string>1751-2824</json:string></eissn><publisherId><json:string>VOXS</json:string></publisherId><volume>6</volume><issue>2</issue><pages><first>387</first><last>390</last><total>4</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>22nd Regional Congress of the ISBT – Asia, Taipei, Taiwan, November 19–23, 2011</value></json:item><json:item><value>State of the Art Presentations</value></json:item><json:item><value>STATE OF THE ART</value></json:item></subject></host><namedEntities><unitex><date><json:string>2011</json:string><json:string>7-3-1</json:string></date><geogName></geogName><orgName><json:string>Working Party</json:string><json:string>ISBT Working Party on Granulocyte Immunobiology</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>Yoichi Shibata</json:string><json:string>Nelson H. Tsuno</json:string><json:string>M. Matsuhashi</json:string></persName><placeName><json:string>Japan</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>[1]</json:string><json:string>[3]</json:string><json:string>[5]</json:string><json:string>Araki et al. [2]</json:string><json:string>N. H. Tsuno et al.</json:string><json:string>[2]</json:string><json:string>Yasui et al. [4]</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/WNG-XMLB41H6-R</json:string></ark><categories><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2011</publicationDate><copyrightDate>2011</copyrightDate><doi><json:string>10.1111/j.1751-2824.2011.01520.x</json:string></doi><id>F9ACF182FF33253B045DC88AB200CDA320ED3514</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XMLB41H6-R/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XMLB41H6-R/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-XMLB41H6-R/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Granulocyte antibody detection – the role of MPHA</title><title level="a" type="short">Granulocyte antibody detection by MPHA</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><availability><licence>© 2011 The Author(s). ISBT Science Series © 2011 International Society of Blood Transfusion</licence></availability><date type="published" when="2011-12"></date></publicationStmt><notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Granulocyte antibody detection – the role of MPHA</title><title level="a" type="short">Granulocyte antibody detection by MPHA</title><author xml:id="author-0000"><persName><forename type="first">N. H.</forename><surname>Tsuno</surname></persName><affiliation><orgName type="division">Department of Transfusion Medicine</orgName><orgName type="institution">The University of Tokyo</orgName><address><addrLine>Tokyo</addrLine><addrLine>Japan</addrLine><country key="JP" xml:lang="en">JAPAN</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">M.</forename><surname>Matsuhashi</surname></persName><affiliation><orgName type="division">Department of Transfusion Medicine</orgName><orgName type="institution">The University of Tokyo</orgName><address><addrLine>Tokyo</addrLine><addrLine>Japan</addrLine><country key="JP" xml:lang="en">JAPAN</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">K.</forename><surname>Takahashi</surname></persName><affiliation><orgName type="division">Department of Transfusion Medicine</orgName><orgName type="institution">The University of Tokyo</orgName><address><addrLine>Tokyo</addrLine><addrLine>Japan</addrLine><country key="JP" xml:lang="en">JAPAN</country></address></affiliation></author><idno type="istex">F9ACF182FF33253B045DC88AB200CDA320ED3514</idno><idno type="ark">ark:/67375/WNG-XMLB41H6-R</idno><idno type="DOI">10.1111/j.1751-2824.2011.01520.x</idno><idno type="unit">VOXS1520</idno><idno type="toTypesetVersion">file:VOXS.VOXS1520.pdf</idno></analytic><monogr><title level="j" type="main">ISBT Science Series</title><title level="j" type="sub">State of the Art Presentations, 22nd Regional Congress of the ISBT – Asia, Taipei, Taiwan, November 19–23, 2011</title><title level="j" type="alt">ISBT SCIENCE SERIES</title><idno type="pISSN">1751-2816</idno><idno type="eISSN">1751-2824</idno><idno type="book-DOI">10.1111/(ISSN)1751-2824</idno><idno type="book-part-DOI">10.1111/voxs.2011.6.issue-2</idno><idno type="product">VOXS</idno><idno type="publisherDivision">ST</idno><imprint><biblScope unit="vol">6</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="387">387</biblScope><biblScope unit="page" to="390">390</biblScope><biblScope unit="page-count">4</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2011-12"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract xml:lang="en" style="main"><p>Human neutrophil antigens (HNA) are involved in the pathogenesis of a variety of clinical conditions, such as neonatal immune neutropenia (NIN), refractoriness to granulocyte transfusions, alloimune neutropenia after bone marrow transplantation, febrile transfusion reactions, and transfusion‐related acute lung injury (TRALI). The accurate detection of granulocyte antibodies is essential for the diagnosis and prevention of the clinical conditions in which these antibodies are involved, especially TRALI. The international granulocyte immunology workshop recommends the use of granulocyte agglutination test (GAT) and granulocyte immunofluorescence test (GIFT) for the screening of granulocyte antibody, and the use of monoclonal antibody‐specific immobilization of granulocyte antigen (MAIGA) assay for the determination of the antibody specificity. Presently, however, no single technique available is enough to detect all clinically relevant granulocyte antibodies. Here, we describe the advantages and disadvantages of the mixed‐passive hemagglutination (MPHA) assay in the general context of granulocyte serology.</p></abstract><textClass><keywords xml:lang="en"><term xml:id="k1">GAT</term><term xml:id="k2">GIFT</term><term xml:id="k3">Human neutrophil antigens</term><term xml:id="k4">MAIGA</term><term xml:id="k5">MPHA</term><term xml:id="k6">TRALI</term></keywords><keywords rend="tocHeading1"><term>22nd Regional Congress of the ISBT – Asia, Taipei, Taiwan, November 19–23, 2011</term></keywords><keywords rend="tocHeading2"><term>State of the Art Presentations</term></keywords><keywords rend="articleCategory"><term>STATE OF THE ART</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XMLB41H6-R/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1751-2824</doi><issn type="print">1751-2816</issn><issn type="electronic">1751-2824</issn><idGroup><id type="product" value="VOXS"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="ISBT SCIENCE SERIES">ISBT Science Series</title></titleGroup></publicationMeta><publicationMeta level="part" position="12102"><doi origin="wiley">10.1111/voxs.2011.6.issue-2</doi><titleGroup><title type="specialIssueTitle">State of the Art Presentations, 22nd Regional Congress of the ISBT – Asia, Taipei, Taiwan, November 19–23, 2011</title></titleGroup><numberingGroup><numbering type="journalVolume" number="6">6</numbering><numbering type="journalIssue">2</numbering></numberingGroup><coverDate startDate="2011-12">December 2011</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="31" status="forIssue"><doi origin="wiley">10.1111/j.1751-2824.2011.01520.x</doi><idGroup><id type="unit" value="VOXS1520"></id></idGroup><countGroup><count type="pageTotal" number="4"></count></countGroup><titleGroup><title type="tocHeading1">22<sup>nd</sup> Regional Congress of the ISBT – Asia, Taipei, Taiwan, November 19–23, 2011</title><title type="tocHeading2">State of the Art Presentations</title><title type="articleCategory">STATE OF THE ART<link href="#artCateg-note"></link></title></titleGroup><copyright>© 2011 The Author(s). ISBT Science Series © 2011 International Society of Blood Transfusion</copyright><eventGroup><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.10 mode:FullText" date="2011-10-20"></event><event type="firstOnline" date="2011-10-20"></event><event type="publishedOnlineFinalForm" date="2011-10-20"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-10"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-23"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="387">387</numbering><numbering type="pageLast" number="390">390</numbering></numberingGroup><correspondenceTo>Nelson H. Tsuno, Department of Transfusion Medicine, The University of Tokyo, 7‐3‐1 Hongo, Bunkyo‐ku, Tokyo 113‐8655, Japan
E‐mail: <email normalForm="tsuno-tky@umin.net">tsuno‐tky@umin.net</email></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:VOXS.VOXS1520.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="3"></count><count type="tableTotal" number="0"></count></countGroup><titleGroup><title type="main">Granulocyte antibody detection – the role of MPHA</title><title type="shortAuthors">N. H. Tsuno <i>et al.</i></title><title type="short">Granulocyte antibody detection by MPHA</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#aff-1-1"><personName><givenNames>N. H.</givenNames><familyName>Tsuno</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#aff-1-1"><personName><givenNames>M.</givenNames><familyName>Matsuhashi</familyName></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#aff-1-1"><personName><givenNames>K.</givenNames><familyName>Takahashi</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="aff-1-1" countryCode="JP"><unparsedAffiliation>Department of Transfusion Medicine, The University of Tokyo, Tokyo, Japan</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en"><keyword xml:id="k1">GAT</keyword><keyword xml:id="k2">GIFT</keyword><keyword xml:id="k3">Human neutrophil antigens</keyword><keyword xml:id="k4">MAIGA</keyword><keyword xml:id="k5">MPHA</keyword><keyword xml:id="k6">TRALI</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><p>Human neutrophil antigens (HNA) are involved in the pathogenesis of a variety of clinical conditions, such as neonatal immune neutropenia (NIN), refractoriness to granulocyte transfusions, alloimune neutropenia after bone marrow transplantation, febrile transfusion reactions, and transfusion‐related acute lung injury (TRALI). The accurate detection of granulocyte antibodies is essential for the diagnosis and prevention of the clinical conditions in which these antibodies are involved, especially TRALI. The international granulocyte immunology workshop recommends the use of granulocyte agglutination test (GAT) and granulocyte immunofluorescence test (GIFT) for the screening of granulocyte antibody, and the use of monoclonal antibody‐specific immobilization of granulocyte antigen (MAIGA) assay for the determination of the antibody specificity. Presently, however, no single technique available is enough to detect all clinically relevant granulocyte antibodies. Here, we describe the advantages and disadvantages of the mixed‐passive hemagglutination (MPHA) assay in the general context of granulocyte serology.</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="artCateg-note" numbered="no"><p>4A‐S12‐02</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Granulocyte antibody detection – the role of MPHA</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Granulocyte antibody detection by MPHA</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Granulocyte antibody detection – the role of MPHA</title></titleInfo><name type="personal"><namePart type="given">N. H.</namePart><namePart type="family">Tsuno</namePart><affiliation>Department of Transfusion Medicine, The University of Tokyo, Tokyo, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Matsuhashi</namePart><affiliation>Department of Transfusion Medicine, The University of Tokyo, Tokyo, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Takahashi</namePart><affiliation>Department of Transfusion Medicine, The University of Tokyo, Tokyo, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">2011-12</dateIssued><copyrightDate encoding="w3cdtf">2011</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><extent unit="figures">3</extent><extent unit="tables">0</extent></physicalDescription><abstract lang="en">Human neutrophil antigens (HNA) are involved in the pathogenesis of a variety of clinical conditions, such as neonatal immune neutropenia (NIN), refractoriness to granulocyte transfusions, alloimune neutropenia after bone marrow transplantation, febrile transfusion reactions, and transfusion‐related acute lung injury (TRALI). The accurate detection of granulocyte antibodies is essential for the diagnosis and prevention of the clinical conditions in which these antibodies are involved, especially TRALI. The international granulocyte immunology workshop recommends the use of granulocyte agglutination test (GAT) and granulocyte immunofluorescence test (GIFT) for the screening of granulocyte antibody, and the use of monoclonal antibody‐specific immobilization of granulocyte antigen (MAIGA) assay for the determination of the antibody specificity. Presently, however, no single technique available is enough to detect all clinically relevant granulocyte antibodies. Here, we describe the advantages and disadvantages of the mixed‐passive hemagglutination (MPHA) assay in the general context of granulocyte serology.</abstract><subject lang="en"><genre>keywords</genre><topic>GAT</topic><topic>GIFT</topic><topic>Human neutrophil antigens</topic><topic>MAIGA</topic><topic>MPHA</topic><topic>TRALI</topic></subject><relatedItem type="host"><titleInfo><title>ISBT Science Series</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>22nd Regional Congress of the ISBT – Asia, Taipei, Taiwan, November 19–23, 2011</topic><topic>State of the Art Presentations</topic><topic>STATE OF THE ART</topic></subject><identifier type="ISSN">1751-2816</identifier><identifier type="eISSN">1751-2824</identifier><identifier type="DOI">10.1111/(ISSN)1751-2824</identifier><identifier type="PublisherID">VOXS</identifier><part><date>2011</date><detail type="title"><title>State of the Art Presentations, 22nd Regional Congress of the ISBT – Asia, Taipei, Taiwan, November 19–23, 2011</title></detail><detail type="volume"><caption>vol.</caption><number>6</number></detail><detail type="issue"><caption>no.</caption><number>2</number></detail><extent unit="pages"><start>387</start><end>390</end><total>4</total></extent></part></relatedItem><relatedItem type="references" displayLabel="cit1"><titleInfo><title>Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody‐mediated transfusion‐related acute lung injury</title></titleInfo><name type="corporate"><namePart>ISBT Working Party on Granulocyte Immunobiology</namePart></name><genre>journal-article</genre><note type="citation/reference">ISBT Working Party on Granulocyte Immunobiology: Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody‐mediated transfusion‐related acute lung injury. Vox Sang 2009; 96:266–269</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>266</start><end>269</end></extent></part><relatedItem type="host"><titleInfo><title>Vox Sang</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>266</start><end>269</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit2"><titleInfo><title>Anti‐granulocyte antibody screening with extracted granulocyte antigens by a micro‐mixed passive hemagglutination method</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Araki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Nose</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Kohsaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Mito</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Ito</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Araki N, Nose Y, Kohsaki M, Mito H, Ito K: Anti‐granulocyte antibody screening with extracted granulocyte antigens by a micro‐mixed passive hemagglutination method. Vox Sang 1999; 77:44–51</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>77</number></detail><extent unit="pages"><start>44</start><end>51</end></extent></part><relatedItem type="host"><titleInfo><title>Vox Sang</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>77</number></detail><extent unit="pages"><start>44</start><end>51</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit3"><titleInfo><title>IgM alloantibody detection by M‐MPHA, a new solid‐phase assay system</title></titleInfo><name type="personal"><namePart type="given">T</namePart><namePart type="family">Toyohiro</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I</namePart><namePart type="family">Yasuyuki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Toshio</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Toyohiro T, Yasuyuki I, Toshio M: IgM alloantibody detection by M‐MPHA, a new solid‐phase assay system. Transfus Sci 2000; 23(1):47–54</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>47</start><end>54</end></extent></part><relatedItem type="host"><titleInfo><title>Transfus Sci</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>47</start><end>54</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit4"><titleInfo><title>Establishment of cell lines stably expressing HNA‐1a, ‐1b, and ‐2a antigen with low background reactivity in flow cytometric analysis</title></titleInfo><name type="personal"><namePart type="given">K</namePart><namePart type="family">Yasui</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Miyazaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Matsuyama</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Kojima</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RA</namePart><namePart type="family">Furuta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Fujisawa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Tani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Shibata</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Sato</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Kato</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Ikeda</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Hirayama</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yasui K, Miyazaki T, Matsuyama N, Kojima Y, Furuta RA, Fujisawa J, Tani Y, Shibata H, Sato S, Kato T, Ikeda H, Hirayama F: Establishment of cell lines stably expressing HNA‐1a, ‐1b, and ‐2a antigen with low background reactivity in flow cytometric analysis. Transfusion 2007; 47(3):478–485</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><detail type="issue"><caption>no.</caption><number>3</number></detail><extent unit="pages"><start>478</start><end>485</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><detail type="issue"><caption>no.</caption><number>3</number></detail><extent unit="pages"><start>478</start><end>485</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit5"><titleInfo><title>New cell lines express HNA‐1c, ‐4a, ‐4b, ‐5a, or ‐5b for identification of HNA antibodies</title></titleInfo><name type="personal"><namePart type="given">K</namePart><namePart type="family">Yasui</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Hirayama</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Matsuyama</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RA</namePart><namePart type="family">Furuta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Kimura</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Tani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Shibata</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Odagiri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Watanabe</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yasui K, Hirayama F, Matsuyama N, Furuta RA, Kimura T, Tani Y, Shibata H, Odagiri M, Watanabe Y: New cell lines express HNA‐1c, ‐4a, ‐4b, ‐5a, or ‐5b for identification of HNA antibodies. Transfusion 2008; 48(5):1037–1039</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><detail type="issue"><caption>no.</caption><number>5</number></detail><extent unit="pages"><start>1037</start><end>1039</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><detail type="issue"><caption>no.</caption><number>5</number></detail><extent unit="pages"><start>1037</start><end>1039</end></extent></part></relatedItem></relatedItem><identifier type="istex">F9ACF182FF33253B045DC88AB200CDA320ED3514</identifier><identifier type="ark">ark:/67375/WNG-XMLB41H6-R</identifier><identifier type="DOI">10.1111/j.1751-2824.2011.01520.x</identifier><identifier type="ArticleID">VOXS1520</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2011 The Author(s). ISBT Science Series © 2011 International Society of Blood Transfusion</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-16</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XMLB41H6-R/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000642 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000642 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:F9ACF182FF33253B045DC88AB200CDA320ED3514
|texte= Granulocyte antibody detection – the role of MPHA
}}
| This area was generated with Dilib version V0.6.33. |  |